Cell & Gene Therapy Drug Delivery Devices

Cell & Gene Therapy Drug Delivery Devices Market Research Report: Forecast (2022-2028)

By Product Type (Subretinal Injection Cannula, Extension Tube, Intravenous Catheter, Sterile Insulin Syringe (Size 1.0 ML, 31-Gauge Needle), (Size 0.5 ML, 22-Gauge Needle)), Pre-Filled Syringe (Size 1 Read more

  • Healthcare
  • Oct 2021
  • 221
  • HC55022

Cell & gene therapies involve the extraction of protein, cells, or genetic material from the patient, modifying them, and then re-injecting into the patient to provide a highly personalized treatment. These therapies have immense potential to display long-lasting effects. In addition, the overall accuracy & ability to eliminate cancer cells without damaging healthy tissues is increasing rapidly worldwide, which, in turn, is propelling the demand for these therapies & their drug delivery devices.

The Global Cell & Gene Therapy Drug Delivery Devices Market is anticipated to grow at a CAGR of around 14% during the forecast period, i.e., 2022-28, says MarkNtel Advisors. The market is driven primarily by massive funding by numerous leading players in the technological advancements to bring cost-effective therapies & devices, coupled with the increasing number of FDA approvals for cell & gene therapies & clinical trials.

Furthermore, the rising number of FDA Approvals of Cell & Gene Therapies and clinical trials to develop new medical products and provide patients with increased therapeutic choices shall also boost the market in the coming years, further states the research report, "Global Cell & Gene Therapy Drug Delivery Devices Market Analysis, 2022."

Report Coverage Details
Study Period Historical Data: 2018-20
Base Year: 2021
Forecast Period: 2022-28
CAGR 14%
Regions Covered North America: USA, Canada, Mexico
Europe: Germany, UK, France, Italy, Spain
Asia-Pacific: China, India, Japan, South Korea
South America: Brazil, and Argentina
Middle East & Africa: UAE, Saudi Arabia, Qatar, Israel, South Africa
Key Companies Profiled Amgen Inc., Bausch & Lomb Incorporated, Becton, Dickinson and Company, Bluebird bio Inc., Castle Creek Biosciences, Inc. (Fibrocell Science, Inc.), Dendreon Pharmaceuticals LLC, Helixmith Co. Ltd (ViroMed Co., Ltd), Human Stem Cells Institute, Kite Pharma Inc., Kolon TissueGene, Inc., Novartis AG, Orchard Therapeutics plc., Pfizer Inc., Renova Therapeutics, Spark Therapeutics Inc., uniQure N.V., Vericel Corporation
Unit Denominations USD Million/Billion

 

Covid-19 Severely Impacted the Global Cell & Gene Therapy Drug Delivery Devices Market

Last year, the outbreak of the Covid-19 made a decelerating impact on most industries where the Global Cell & Gene Therapy Drug Delivery Devices Market was no exception.

The market dynamics underwent significant disruptions in manufacturing & logistics processes and faced substantial complexities in the supply chain of materials. Owing to this, many clinical centers had to suspend their operations to combat the risk of virus exposure. Moreover, shipment delays risked the short shelf lives of cell therapies that need transportation across manufacturing sites & administration centers within tight timeframes.

However, observing the increasing spread of the dreadful disease, market players shifted their focus majorly on addressing challenges associated with the pandemic. Numerous gene therapy companies got involved in the research & manufacturing of Covid-19 vaccinations since the currently available ones are authorized for clinical development & based on mRNA or viral vector approaches. As a result, prices & reimbursements of Competitive Generic Therapy (CGTs) expanded significantly.

  1. Introduction
    1. Product Definition
    2. Research Process
    3. Assumptions
    4. Market Segmentation
  2. Executive Summary
  3. Impact of Covid-19 on Global Cell & Gene Therapy Drug Delivery Devices Market
  4. Global Cell & Gene Therapy Drug Delivery Devices Market Policies & Regulations
  5. Global Cell & Gene Therapy Drug Delivery Devices Success & Growth
  6. Global Cell & Gene Therapy Drug Delivery Devices Market Trends & Insights
  7. Global Cell & Gene Therapy Drug Delivery Devices Market Dynamics
    1. Impact Analysis
    2. Drivers
    3. Challenges
  8. Global Cell & Gene Therapy Drug Delivery Devices Market Trends & Development
  9. Global Cell & Gene Therapy Drug Delivery Devices Market Analysis, 2018-2028
    1. Market Size & Analysis
      1. By Revenue
      2. By Unit Sold
    2. Market Share & Analysis
      1. By Product Type
        1. Sub-retinal Injection Cannula
        2. Extension Tube
        3. Intravenous Catheter
        4. Sterile Insulin Syringe
          1. Size 1.0 ML, 31-Gauge Needle
          2. Size 0.5 ML, 22-Gauge Needle
        5.  Pre-Filled Syringe
          1. Size 1.0 ML, 22-26 Gauge Needle
          2. Size 4.0 ML, 22-26 Gauge Needle
        6.  Infusion Bags
          1. Infusion Bags (Size 10 ML to 50 ML)
          2. Infusion Bags (Size 68 ML)
          3. Infusion Bags (Size 60 ML)
          4. Infusion Bags (Size Up to 65 ML)
      2. By Technology
        1. Microchip Technology
        2. Nano-Technology
        3. Lipid Nanoparticles
      3. By Commercialized Drugs
        1. Luxturna
        2. Kymriah
        3. Yescarta
        4. Zolgensma
        5. Provenge
        6. Strimvelis
      4. By End-User
        1. Pharmaceuticals & Biotechnology Company
        2. Academic & Research Institute
        3. Hospitals & Clinics
      5. By Region
        1. North America
        2. South America
        3. Europe
        4. Middle East & Africa
        5. Asia-Pacific
  10. North America Cell & Gene Therapy Drug Delivery Devices Market Outlook, 2018-2028
    1. Market Size & Analysis
      1. By Revenue
      2. By Unit Sold
    2. Market Share & Analysis
      1. By Product Type
      2. By Technology
      3. By Commercialized Drugs
      4. By End-User
      5. By Country
        1. US
        2. Canada
        3. Mexico
    3. The US Cell & Gene Therapy Drug Delivery Devices Market Outlook, 2018-2028
      1. Market Size & Analysis
        1. By Revenue
        2. By Unit Sold
      2. Market Share & Analysis
        1. By Product Type
        2. By Technology
    4. Canada Cell & Gene Therapy Drug Delivery Devices Market Outlook, 2018-2028
      1. Market Size & Analysis
        1. By Revenue
        2. By Unit Sold
      2. Market Share & Analysis
        1. By Product Type
        2. By Technology
    5. Mexico Cell & Gene Therapy Drug Delivery Devices Market Outlook, 2018-2028
      1. Market Size & Analysis
        1. By Revenue
        2. By Unit Sold
      2. Market Share & Analysis
        1. By Product Type
        2. By Technology
  11. South America Cell & Gene Therapy Drug Delivery Devices Market Outlook, 2018-2028
    1. Market Size & Analysis
      1. By Revenue
      2. By Unit Sold
    2. Market Share & Analysis
      1. By Product Type
      2. By Technology
      3. By Commercialized Drugs
      4. By End-User
      5. By Country
        1. Brazil
        2. Argentina
        3. Others
    3. Brazil Cell & Gene Therapy Drug Delivery Devices Market Outlook, 2018-2028
      1. Market Size & Analysis
        1. By Revenue
        2. By Unit Sold
      2. Market Share & Analysis
        1. By Product Type
    4. Argentina Cell & Gene Therapy Drug Delivery Devices Market Outlook, 2018-2028
      1. Market Size & Analysis
        1. By Revenue
        2. By Unit Sold
      2. Market Share & Analysis
        1. By Product Type
        2. By Technology
  12. Europe Cell & Gene Therapy Drug Delivery Devices Market Outlook, 2018-2028
    1. Market Size & Analysis
      1. By Revenue
      2. By Unit Sold
    2. Market Share & Analysis
      1. By Product Type
      2. By Technology
      3. By Commercialized Drugs
      4. By End-User
      5. By Country
        1. The UK
        2. Spain
        3. Italy
        4. France
        5. Germany
        6. Others
    3. The UK Cell & Gene Therapy Drug Delivery Devices Market Outlook, 2018-2028
      1. Market Size & Analysis
        1. By Revenue
        2. By Unit Sold
      2. Market Share & Analysis
        1. By Product Type
        2. By Technology
    4. France Cell & Gene Therapy Drug Delivery Devices Market Outlook, 2018-2028
      1. Market Size & Analysis
        1. By Revenue
        2. By Unit Sold
      2. Market Share & Analysis
        1. By Product Type
        2. By Technology
    5. Germany Cell & Gene Therapy Drug Delivery Devices Market Outlook, 2018-2028
      1. Market Size & Analysis
        1. By Revenue
        2. By Unit Sold
      2. Market Share & Analysis
        1. By Product Type
        2. By Technology
    6. Spain Cell & Gene Therapy Drug Delivery Devices Market Outlook, 2018-2028
      1. Market Size & Analysis
        1. By Revenue
        2. By Unit Sold
      2. Market Share & Analysis
        1. By Product Type
        2. By Technology
    7. Italy Cell & Gene Therapy Drug Delivery Devices Market Outlook, 2018-2028
      1. Market Size & Analysis
        1. By Revenue
        2. By Unit Sold
      2. Market Share & Analysis
        1. By Product Type
        2. By Technology
  13. Middle East & Africa Cell & Gene Therapy Drug Delivery Devices Market Outlook, 2018-2028
    1. Market Size & Analysis
      1. By Revenue
      2. By Unit Sold
    2. Market Share & Analysis
      1. By Product Type
      2. By Technology
      3. By Commercialized Drugs
      4. By End-User
      5. By Country
        1. Saudi Arabia
        2. The UAE
        3. Qatar
        4. Israel
        5. South Africa
        6. Others
  14. Asia-Pacific Cell & Gene Therapy Drug Delivery Devices Market Outlook, 2018-2028
    1. Market Size & Analysis
      1. By Revenue
      2. By Unit Sold
    2. Market Share & Analysis
      1. By Product Type
      2. By Technology
      3. By Commercialized Drugs
      4. By End-User
      5. By Country
        1. India
        2. China
        3. Japan
        4. South Korea
        5. Others
    3. China Cell & Gene Therapy Drug Delivery Devices Market Outlook, 2018-2028
      1. Market Size & Analysis
        1. By Revenue
        2. By Unit Sold
      2. Market Share & Analysis
        1. By Product Type
        2. By Technology
    4. India Cell & Gene Therapy Drug Delivery Devices Market Outlook, 2018-2028
      1. Market Size & Analysis
        1. By Revenue
        2. By Unit Sold
      2. Market Share & Analysis
        1. By Product Type
        2. By Technology
    5. Japan Cell & Gene Therapy Drug Delivery Devices Market Outlook, 2018-2028
      1. Market Size & Analysis
        1. By Revenue
        2. By Unit Sold
      2. Market Share & Analysis
        1. By Product Type
        2. By Technology
    6. South Korea Cell & Gene Therapy Drug Delivery Devices Market Outlook, 2018-2028
      1. Market Size & Analysis
        1. By Revenue
        2. By Unit Sold
      2. Market Share & Analysis
        1. By Product Type
        2. By Technology
  15. Competitive Benchmarking
    1. Competition Matrix
      1. Company Overview
      2. Product/Business Segment Overview
      3. Regulatory & Legal Development
      4. Company Strategies
      5. SWOT Analysis
  16. Company Profile
    1. Amgen Inc.
    2. Bausch & Lomb Incorporated
    3. Becton, Dickinson and Company
    4. Bluebird bio Inc.
    5. Castle Creek Biosciences, Inc. (Fibrocell Science, Inc.)
    6. Dendreon Pharmaceuticals LLC
    7. Helixmith Co. Ltd (ViroMed Co., Ltd)
    8. Human Stem Cells Institute
    9. Kite Pharma Inc.
    10. Kolon TissueGene, Inc.
    11. Novartis AG
    12. Orchard Therapeutics plc.
    13. Pfizer Inc.
    14. Renova Therapeutics
    15. Spark Therapeutics Inc.
    16. uniQure N.V.
    17. Vericel Corporation
  17. Disclaimer
Cell Gene Therapy Drug Delivery Devices Market Segmentation
*This field is required